Fu et al., reported 18.3% of women with NSCLC vs 26% of men with PD-L1 TPS of 1-49%, and only 5.5% of women vs 17% of men with PD-L1 TPS ≥ 50% (49). This evidence concerns the gene CD274 and non-small cell lung carcinoma.